| Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone … I Jambor, A Kuisma, S Ramadan, R Huovinen, M Sandell, S Kajander, ... Acta oncològica 55 (1), 59-67, 2016 | 229 | 2016 |
| In Vivo Imaging of Prostate Cancer Using [68Ga]-Labeled Bombesin Analog BAY86-7548 E Kähkönen, I Jambor, J Kemppainen, K Lehtiö, TJ Grönroos, A Kuisma, ... Clinical cancer research 19 (19), 5434-5443, 2013 | 217 | 2013 |
| Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial) I Jambor, A Kuisma, E Kähkönen, J Kemppainen, H Merisaari, O Eskola, ... European journal of nuclear medicine and molecular imaging 45, 355-364, 2018 | 73 | 2018 |
| Comparison of standardized uptake values between 99mTc-HDP SPECT/CT and 18F-NaF PET/CT in bone metastases of breast and prostate cancer S Arvola, I Jambor, A Kuisma, J Kemppainen, S Kajander, M Seppänen, ... EJNMMI research 9, 1-9, 2019 | 55 | 2019 |
| Safety, biodistribution, and radiation dosimetry of 18F-rhPSMA-7.3 in healthy adult volunteers T Tolvanen, K Kalliokoski, S Malaspina, A Kuisma, S Lahdenpohja, ... Journal of Nuclear Medicine 62 (5), 679-684, 2021 | 23 | 2021 |
| Validation of automated magnetic resonance image segmentation for radiation therapy planning in prostate cancer A Kuisma, I Ranta, J Keyriläinen, S Suilamo, P Wright, M Pesola, ... Physics and imaging in radiation oncology 13, 14-20, 2020 | 19 | 2020 |
| Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2 … I Saarinen, I Jambor, M Kim, A Kuisma, J Kemppainen, H Merisaari, ... EJNMMI research 9, 1-11, 2019 | 16 | 2019 |
| Kinetic analysis and optimisation of 18F-rhPSMA-7.3 PET imaging of prostate cancer S Malaspina, V Oikonen, A Kuisma, O Ettala, K Mattila, PJ Boström, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 3723-3731, 2021 | 14 | 2021 |
| Uptake of 18F-rhPSMA-7.3 in Positron Emission Tomography Imaging of Prostate Cancer: A Phase 1 Proof-of-Concept Study S Malaspina, P Taimen, M Kallajoki, V Oikonen, A Kuisma, O Ettala, ... Cancer Biotherapy & Radiopharmaceuticals 37 (3), 205-213, 2022 | 9 | 2022 |
| Prospective evaluation of planar bone scintigraphy, SPECT/CT, 18F NAF PET/CT and whole body 1.5 T MRI for detection of bone metastases in high risk breast and prostate cancer … AK Kuisma, I Jambor, R Huovinen, M Sandell Annals of Oncology 23, ix384, 2012 | 6 | 2012 |
| Comparison of standardized uptake values between 99mTc-HDP SPECT/CT and 18F-NaF PET/CT in bone metastases of breast and prostate cancer. EJNMMI Res. 2019; 9 (1): 6 S Arvola, I Jambor, A Kuisma, J Kemppainen, S Kajander, M Seppänen Přejít k původnímu zdroji... Přejít na PubMed, 2011 | 5 | 2011 |
| Prediction of prostate cancer aggressiveness using 18F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI P Movahedi, H Merisaari, IM Perez, P Taimen, J Kemppainen, A Kuisma, ... Scientific Reports 10 (1), 9407, 2020 | 4 | 2020 |
| Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer S Arvola, M Seppänen, S Malaspina, S Mätzke, J Raiko, KL Timonen, ... Nuclear Medicine Communications 43 (5), 510-517, 2022 | 3 | 2022 |
| Long-term outcome of biologically guided dose-escalated radiotherapy of localized prostate cancer A Kuisma, P Wright, S Suilamo, J Seppälä, M Koivisto, P Lindholm, ... Acta Oncologica 61 (1), 97-103, 2022 | 3 | 2022 |
| Detection of prostate cancer using 68Ga-labelled bombesin analogue BAY 86-7548 in patients undergoing radical prostatectomy H Minn, E Kahkonen, I Jambor, J Kemppainen, K Lehtio, A Kuisma, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 39, S255-S255, 2012 | 3 | 2012 |
| Prospective evaluation of planar bone scintigraphy, SPECT/CT, 18F NaF PET/CT and whole body 1.5 T MRI for detection of bone metastases in high risk breast and prostate cancer … I Jambor, A Kuisma, R Huovinen, M Sandell, J Auren, S Kajander, ... Acta Oncologica 55 (1), 59-67, 2013 | 2 | 2013 |
| Kinetic Modelling of F-18-rhPSMA-7.3 Uptake in PET Imaging of Prostate Cancer S Malaspina, V Oikonen, A Kuisma, O Ettala, K Mattila, PJ Bostrom, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 47 (SUPPL 1 …, 2020 | 1 | 2020 |
| Prediction of prostate cancer aggressiveness using ¹⁸F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI P Movahedi, H Merisaari, IM Perez, P Taimen, J Kemppainen, A Kuisma, ... Springer Nature, 2020 | | 2020 |
| Prediction of prostate cancer aggressiveness using 18 F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI M Parisa, M Harri, IM Perez, T Pekka, K Jukka, A Kuisma, E Olli, T Jarmo, ... Scientific Reports (Nature Publisher Group), 2020 | | 2020 |
| ORIGINAL RESEARCH Open Access I Saarinen, I Jambor, M Kim, A Kuisma, J Kemppainen, H Merisaari, ... | | 2019 |
